Drug company Novartis is betting $20 million on a cancer treatment that seems to have saved a little girl's life, according to a report from The New York Times's Denise Grady.

Just last spring, six-year-old leukimia victim Emma Whitehead was "near death," having gone through chemotherapy twice without success.